291 related articles for article (PubMed ID: 8303308)
1. New perspectives in mucosal immunity with emphasis on vaccine development.
McGhee JR; Fujihashi K; Xu-Amano J; Jackson RJ; Elson CO; Beagley KW; Kiyono H
Semin Hematol; 1993 Oct; 30(4 Suppl 4):3-12; discussion 13-5. PubMed ID: 8303308
[TBL] [Abstract][Full Text] [Related]
2. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
3. New generation of mucosal adjuvants for the induction of protective immunity.
Yuki Y; Kiyono H
Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mucosal immune responses by T lymphocytes: the effect of chronic CD4+ T cell deficiency on IgA synthesis.
Mega J; Fujihashi K; Kiyono H
Reg Immunol; 1992; 4(2):70-8. PubMed ID: 1354470
[TBL] [Abstract][Full Text] [Related]
6. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
McGhee JR; Mestecky J
Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
[TBL] [Abstract][Full Text] [Related]
8. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
9. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
Vajdy M; Lycke N
Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068
[TBL] [Abstract][Full Text] [Related]
10. Expression of alpha4beta7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites.
Rott LS; Briskin MJ; Butcher EC
J Leukoc Biol; 2000 Dec; 68(6):807-14. PubMed ID: 11129647
[TBL] [Abstract][Full Text] [Related]
11. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development.
Kiyono H; Bienenstock J; McGhee JR; Ernst PB
Reg Immunol; 1992; 4(2):54-62. PubMed ID: 1503889
[No Abstract] [Full Text] [Related]
12. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
13. New understanding of immunological mechanisms.
Saalmüller A
Vet Microbiol; 2006 Oct; 117(1):32-8. PubMed ID: 16701965
[TBL] [Abstract][Full Text] [Related]
14. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues.
Hiroi T; Yanagita M; Iijima H; Iwatani K; Yoshida T; Takatsu K; Kiyono H
J Immunol; 1999 Jan; 162(2):821-8. PubMed ID: 9916704
[TBL] [Abstract][Full Text] [Related]
16. Local development of effector and memory T helper cells.
Fazilleau N; McHeyzer-Williams LJ; McHeyzer-Williams MG
Curr Opin Immunol; 2007 Jun; 19(3):259-67. PubMed ID: 17420119
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunity: induction, dissemination, and effector functions.
Brandtzaeg P
Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation in vaccine development.
Takahashi H
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):309-28. PubMed ID: 12818619
[TBL] [Abstract][Full Text] [Related]
19. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
20. The anatomy of mucosal immune responses.
Garside P; Millington O; Smith KM
Ann N Y Acad Sci; 2004 Dec; 1029():9-15. PubMed ID: 15681738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
